Xenon Genetics Inc. Changes Name to Xenon Pharmaceuticals Inc.
Xenon's new website address is: www.xenon-pharma.com. Xenon shareholders unanimously approved this change at the Company's Annual General Meeting on June 25, 2004. Xenon's drug programs are based upon novel targets that have a high degree of human validation. The Company's lead program, a small molecule treatment for obesity and metabolic syndrome, is expected to advance into clinical development in early 2005. Xenon's CNS and iron metabolism drug programs are currently in lead optimization.
"We are making significant and rapid progress towards our objective of developing innovative medicines based on genetically defined targets," said Simon Pimstone, President & CEO. "Our strong clinical genetics platform will continue to contribute to our success. The new name more-clearly communicates our progress and business focus."
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.